Clinical Trials Browser

Colony-Stimulating Factors × Plasma cell × Clear all

NCT02334865 2025-05-11

SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy

Phase 1 Active not recruiting

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma

NCT02728102 2024-05-07

Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)

Phase 2 Completed

203 enrolled 25 charts

Hematologic Diseases, Multiple Myeloma